The pre-hospital management of acute heart attacks. Recommendations of a task force of the the European Society of Cardiology and the European Resuscitation Council

European Heart Journal

Volumn 19, Issue 8, 1998, Pages 1140-1164

  Arntz, Hans Richard ^a   Bossaert, Leo ^a   Carli, Pierre ^a   Chamberlain, Douglas ^a   Davies, Michael ^a   Dellborg, Mikael ^a   Dick, Wolfgang ^a   Haghfelt, Torben ^a   Hapnes, Svein ^a   Juchems, Rudolf ^a   Loewel, Hannelore ^a   Koster, Rudy ^a   Leizorovicz, Alain ^a   Marzilli, Mario ^a   Rawles, John ^a   Robertson, Colin ^a   Ruano, Miguel ^a  

^a NONE

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Sudden cardiac death

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; AMBULANCE; ANALGESIA; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; DEFIBRILLATION; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HEALTH CARE ACCESS; HEART ARREST; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LAW; MEDICAL DECISION MAKING; MORTALITY; NAUSEA; PATHOPHYSIOLOGY; PATIENT TRANSPORT; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOLOGICAL ASPECT; RESUSCITATION; REVIEW; SUDDEN DEATH; SURVIVAL; TIME; VOMITING;

ALGORITHMS; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTRIC COUNTERSHOCK; EMERGENCY MEDICAL SERVICES; EUROPE; HEART ARREST; HUMANS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TRANSPORTATION OF PATIENTS; TRIAGE;

EID: 0032146984     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1106     Document Type: Review

References (148)

1. [1] The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17: 43-63.
2. [2] Chambless L, Keil U, Dobson A, Mähönen M et al. for the WHO MONICA Project. Population versus clinical view of case fatality from acute coronary heart disease: Results from the WHO MONICA Project 1985-1990. Circulation 1997; 96: 3849-59.
3. [3] Sans S, Kesteloot H, Kromhout D on behalf of the Task Force. The burden of cardiovascular mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231-48.
4. [4] Norris RM on behalf of The United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British health districts: 1994-5. Br Med J 1998; 316: 1065-70.
5. [5] Löwel H, Lewis M, Hörmann A. Prognostic significance of the pre-hospital phase in acute myocardial infaction: results of the Augsburg infarct register, 1985-1988 (in German). Dtsch Med Wschr 1991; 116: 729-33.
6. [6] Dellborg M, Eriksson P, Riha M, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994; 15: 5-9.
7. [7] Koenig W, Löwel H, Lewis M, Hörmann A. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg myocardial infarction follow-up study 1985 to 1993. Eur Heart J 1996; 17: 1199-1206.
8. [8] Löwel H, Lewis M, Keil U et al. Time trends of acute myocardial infarction morbidity, mortality, 28-day-case-fatality and acute medical care: results of the Augsburg myocardial infarction register from 1985 to 1992 (in German). Zeitschrift für Kardiol 1995; 84: 596-605.
9. [9] Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996; 93: 1981-92.
10. [10] Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
11. [11] Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-94.
12. [12] Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 1995; 25 (Suppl): 3S-9S.
13. [13] Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-5.
14. [14] Charney R, Cohen M. The role of the coronary circulation in limiting myocardial ischemia and infarct size. Am Heart J 1993; 126: 937-45.
15. [15] Rentrop KP. Thrombolytic therapy in patients with acute myocardial infarction. Circulation 1985; 71: 627-31.
16. [16] Rogers WJ, Hood WP, Mantle JA et al. Return of left ventricular function after reperfusion in patients with myocardial infarction: importance of subtotal stenoses or intact collaterals. Circulation 1984; 69: 338-49.
17. [17] Anzai T, Yoshikawa T, Asakura Y et al. Preinfarction angina as a major predictor of left ventricular function an long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995; 26: 319-27.
18. [18] Lesnefsky EJ, Lundergan CF, Hodgson JMcB et al. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J Am Coll Cardiol 1996; 28: 331-7.
19. [19] Haider AW, Andreotti F, Hackett DR et al. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage. J Am Coll Cardiol 1995; 26: 662-7.
20. [20] Kannel WB, Thomas HE. Sudden coronary death: the Framingham study. Ann NY Acad Sci 1982; 382: 3-21.
21. [21] Wennerblom B, Holmberg S. Death outside hospital with special reference to heart disease. Eur Heart J 1984; 5: 266-74.
22. [22] O'Doherty M, Taylor DI, Quinn E, Vincent R, Chamberlain DA. Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J 1983; 286: 1405-8.
23. [23] Campbell RWF, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J 1981; 46: 351-7.
24. [24] Viskin S, Belahassen B. Idiopathic ventricular fibrillation. Am Heart J 1990; 120: 661-71.
25. [25] Schaffer WA, Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med 1975; 293: 259-62.
26. [26] Blohm MB, Hartford M, Karlson BW, Luepker RV, Herlitz J. An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital. Heart 1996; 76: 430-4.
27. [27] Meischke H, Ho MT, Eisenberg MS, Schaeffer SM, Larsen MP. Reasons patients with chest pain delay or do not call 911. Ann Emerg Med 1995; 25: 193-7.
28. [28] Hackett TP, Cassem NH. Factors contributing to delay in responding to the signs and symptoms of acute myocardial infarction. Am J Cardiol 1969; 24: 651-8.
29. [29] Gilchrist IC. Patient delay before treatment of myocardial infarction. Br Med J 1973; I: 535-7.
30. [30] Rawles JM, Metcalfe MJ, Shirreffs C, Jennings K, Kenmure ACF. Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction. Eur Heart J 1990; 11: 643-8.
31. [31] Kenyon LW, Ketterer MW, Gheorghiade M, Goldstein S. Psychological factors related to prehospital delay during acute myocardial infarction. Circulation 1991; 84: 1969-76.
32. [32] Trent RJ, Rose EL, Adams JN, Jennings KP, Rawles JM. Delay between the onset of symptoms of acute myocardial infarction and seeking medical assistance is influenced by left ventricular function at presentation. Br Heart J 1995; 73: 125-8.
33. [33] Rawles J, Sinclair C, Waugh N. Call-to-needle times in Grampian: the pivotal role of the general practitioner in achieving early thrombolysis (Abstr). Heart 1996; 75 (Suppl 1): 63.
34. [34] Birkhead JS on behalf of the joint audit committee of the British Cardiac Society and cardiology committee of the Royal College of Physicians of London. Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J 1992; 305: 445-8.
35. [35] Bleeker JK, Simoons ML, Erdman RAM et al. Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, the Netherlands. Br J Gen Pract 1995; 45: 181-4.
36. [36] Leprohon J, Patel VL. Decision-making strategies for telephone triage in emergency medical services. Med Decis Making 1995; 15: 240-53.
37. [37] Sramek M, Post W, Koster RW. Telephone triage of cardiac emergency calls by dispatchers. A prospective study of 1386 emergency calls. Br Heart J 1994; 71: 440-5.
38. [38] Culley LL, Henwood DK, Clark JJ, Eisenberg MS, Horton C. Increasing the efficiency of emergency medical services by using criteria based dispatch. Ann Emerg Med 1994; 24: 867-72.
39. [39] Ahnefeld FW. Die Wiederbelebung bei Kreislaufstillstand. Verhandlungen Deutsche Gesellschaft für Innere Medizin 1968; 74: 279-87.
40. [40] Cummins R, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: the 'chain of survival' concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation 1991; 83: 1832-47.
41. [41] The Council of the European Communities. Council decision of 29/7/91 on the introduction of a single European emergency call number (91/396/EEC). OJ 1991; L217: 6.08.1991.
42. [42] Herlitz J, Ekstrom L, Wennerblom B, Axelsson Å, Bång A, Holmberg S. Effect of bystander initiated cardiopulmonary resuscitation on ventricular fibrillation and survival after witnessed cardiac arrest outside hospital. Br Heart J 1994; 72: 408-12.
43. [43] Bossaert L , Van Hoeyweghen R and Cerebral Resuscitation Study Group. Bystander cardiopulmonary resuscitation (CPR) in out-of-hospital cardiac arrest. Resuscitation 1989; 17 (Suppl): S55-S69.
44. [44] Stults KR, Brown DD, Schug VL, Bean JA. Prehospital defibrillation performed by emergency medical technicians in rural communities. N Engl J Med 1984; 310: 219-23.
45. [45] European Resuscitation Council guidelines for the use of automated external defibrillators by EMS providers and first responders. A statement from the Early Defibrillation Task Force, with contributions from the Working Groups on Basic and Advanced Life Support, and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 1998; 37: 91-4.
46. [46] Weaver WD, Hill D, Fahrenbruch CE, Copass MK, Martin JS, Cobb LA, Hallstrom AP. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. N Engl J Med 1988; 319: 661-6.
47. [47] White RD, Asplin BR, Bugliosi TF, Hankins DG. High discharge survival rate after out-of-hospital ventricular fibrillation with rapid defibrillation by police and paramedics. Ann Emerg Med 1996; 28: 480-5.
48. [48] O'Rourke MF, Donaldson E, Geddes JS. An airline cardiac arrest program. Circulation 1997; 96: 2849-53.
49. [49] Bossaert L, Callanan V, Cummins RO. Early defibrillation. An advisory statement by the Advanced Life Support Working Group of the International Liaison Committee on Resuscitation. Resuscitation 1997; 34: 113-5.
50. [50] Jaggarao NSV, Heber M, Grainger R, Vincent R, Chamberlain DA. Use of an automated external defibrillator by ambulance staff. Lancet 1982; ii: 73-5.
51. [51] Eisenberg MS, Horwood BT, Cummins RO, Reynolds-Haertle R, Hearne TR. Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med 1990; 19: 179-86.
52. [52] Het Belgisch Staatsblad, 1 January 1961; Article 422 bis-ter.
53. [53] Capone RJ, Visco J, Curwen E, VanEvery S. The effect of early prehospital transtelephonic coronary intervention on morbidity and mortality: experience with 284 post myocardial infarction patients in a pilot program. Am Heart J 1984; 107: 1153-60.
54. [54] Culley LL, Clark JJ, Eisenberg MS, Larsen MP. Dispatcher-assisted telephone CPR: common delays and time standards for delivery. Ann Emerg Med 1991; 20: 362-6.
55. [55] Eisenberg MS, Hallstrom AP, Carter WB, Cummins RO, Bergner L, Pierce J. Emergency CPR instructions via the telephone. Am J Public Health 1985; 75: 47-50.
56. [56] GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. Br Med J 1992; 305: 548-53.
57. [57] The European Myocardial Infarction Project Group. Pre-hospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329: 383-9.
58. [58] Grijseels EWM, Deckers JW, Hoes AW et al. Implementation of a pre-hospital decision rule in general practice. Triage of patients with suspected myocardial infarction. Eur Heart J 1996; 17: 89-95.
59. [59] Karagounis L, Ipsen SK, Jessop MR et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1990; 66: 786-91.
60. [60] Assanelli D, Zywietz C, Mertins V, Canclini S, Giovanni G, Vignali S. Digital ECG transmission from ambulance cars with application of the European standard communications protocol Scp-Ecg. Eur Heart J 1996; 17 (Suppl): 579.
61. [61] Jollis JG, DeLong ER, Peterson ED et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996; 335: 1880-7.
62. [62] National heart attack alert program coordinating committee 60 min to treatment working group. Emergency department: rapid identification and treatment of patients with acute myocardial infarction. US Department of Health and Human Services, National Institutes of Health, 1993.
63. [63] Burns JMA, Hogg KJ, Rae AP, Hillis WS, Dann FG. Impact of a policy of direct admission to a coronary care unit on use of thrombolysis treatment. Br Heart J 1989; 61: 322-5.
64. [64] Rosenthal E, Thomas N, Quinn E, Chamberlain D, Vincent R. Transcutaneous pacing for cardiac emergencies. Pace 1988; 11: 2160-7.
65. [65] Tachakra SS, Pawsey S, Beckett M, Potts D, Idowu A. Outcome of patients with chest pain discharged from an accident and emergency department. Br Med J 1991; 302: 504-5.
66. [66] Pell ACH, Miller HC. Delays in admission of patients with myocardial infarction to coronary care: implications for thrombolysis. Health Bull 1990; 48: 225-3.
67. [67] Emerson PA, Russell NJ, Wyatt J et al. An audit of doctor's management of patients with chest pain in the accident and emergency department. Q J Med 1989; 263: 213-20.
68. [68] Pell ACH, Miller HC, Robertson CE, Fox KAA. Effect of 'fast track' admission for acute myocardial infarction on delay to thrombolysis. Br Med J 1992; 304: 83-7.
69. [69] More R, Moore K, Quinn E et al. Delay times in the administration of thrombolytic therapy: the Brighton experience. Int J Cardiol 1995; 49 (Suppl): S39-S46.
70. [70] Goldman L, Cook EF, Brand DA et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Eng J Med 1988; 318: 797-803.
71. [71] Pozen MW, d'Agostino RB, Mitchell JB et al. The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Int Med 1980; 92: 238-42.
72. [72] Tierney WM, Roth BJ, Psaty B et al. Predictors of myocardial infarction in emergency room patients. Crit Care Med 1985; 13: 526-31.
73. [73] Adams J, Trent R, Rawles J on behalf of the GREAT Group. Earliest electrocardiographic evidence of myocardial infarction: implications for thombolytic treatment. Br Med J 1993; 307: 409-13.
74. [74] Srikanthan VS, Pell AC, Prasad N et al. Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart 1997; 78: 198-200.
75. [75] Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-1-6.
76. [76] ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-60.
77. [77] Reilly IA, Fitzgerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 1987; 69: 180-6.
78. [78] Collins R, MacMahon S, Flather M et al. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. Br Med J 1996; 313: 652-9.
79. [79] ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-70.
80. [80] Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71.
81. [81] ISIS-I (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 1986; ii: 57-66.
82. [82] The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 1985; 6: 199-226.
83. [83] Borzak S, Gheorghiade M. Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction: the thrombolysis in myocardial infarction (TIMI-2) trial. Prog Cardiovasc Dis 1993; 36: 261-6.
84. [84] Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progr Cardiovasc Dis 1985; 27: 335-71.
85. [85] The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 1989; 320: 618-27.
86. [86] Leizorovicz A, Teppe J-P, Payen C, Haugh MC, Boissel J-P for EMIP-BB Pilot Study Group. Pre-hospital treatment of patients with suspected acute myocardial using a beta-blocking agent: a double-blind feasibility study. Clin Trials and Meta-Analysis 1994; 29: 125-38.
87. [87] Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
88. [88] ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
89. [89] Ferguson JJ, Diver DJ, Boldt M, Pasternak RC. Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. Am J Cardiol 1989; 64: 311-4.
90. [90] Rutherford JD, Pfeffer MA, Moyé LE et al on behalf of SAVE Investigators. Effects of captopril on ischemic events after myocardial infarction: results of the survival and ventricular enlargement trial. Circulation 1994; 90: 1731-8.
91. [91] Pfeffer MA, Greaves SC, Arnold MO et al. for the Healing and Early Afterload Reducing Therapy (HEART) Trial Investigators. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation 1997; 95: 2643-51.
92. [92] MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988; 260: 1910-6.
93. [93] Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989; 149: 2694-8.
94. [94] Teo KK, Yusuf S, Furberg SD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993; 270: 1589-95.
95. [95] Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
96. [96] Rawles J. What is the likely benefit of earlier thrombolysis? Eur Heart J 1996; 17: 991-5.
97. [97] Weaver WD, Cerqueira M, Hallström AP et al. for the Myocardial infarction Triage and Intervention Project Group. Pre-hospital-initiated vs hospital-initiated thrombolytic therapy. JAMA 1993; 270: 1211-6.
98. [98] Rawles J. Quantification of the benefit of earlier thrombolytic therapy: 5-year results of the Grampian early anistreplase trial (GREAT). J Am Coll Cardiol 1997; 30: 1181-6.
99. [99] Brouwer MA, Martin JS, Maynard JS et al. for the MITI Project Investigators. Influence of early pre-hospital thrombolysis on mortality and event-free survival (The Myocardial Infarction Triage and Intervention [MITI] randomized trial). Am J Cardiol 1996; 78: 497-502.
100. [100] Cannon CP, Antman EM, Walls R, Braunwald E. Time as an adjunctive agent to thrombolytic therapy. J Thrombosis and Thrombolysis 1994; 1: 27-34.
101. [101] Stone GW, Grines CL, Rothbaum D et al. for the PAMI Trial Investigators. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction(PAMI) trial. J Am Coll Cardiol 1997; 29: 901-7.
102. [102] The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-8.
103. [103] Every NR, Parsons LS, Hlaty M, Martin JS, Weaver D, for the Myocardal Infarction Triage and Intervention Investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996; 335: 1253-60.
104. [104] Ellis SG, da Silva ER, Heydricks G et al. For the RESCUE-Investegators. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994; ; 20: 2280-4.
105. [105] McKendall GR, Forman S, Sopko G, Braunwald E, Williams DO, and the Thrombolysis in Myocardial Infarction Investigators. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995; 76: 1108-11.
106. [106] A statement for the Advanced Cardiac Life Support Committee of the European Resuscitation Council, 1994. Management of peri-arrest arrhythmias. Resuscitation 1994; 28: 151-9 (Update: Resuscitation 1996; 31: 281.)
107. [106] A statement for the Advanced Cardiac Life Support Committee of the European Resuscitation Council, 1994. Management of peri-arrest arrhythmias. Resuscitation 1994; 28: 151-9 (Update: Resuscitation 1996; 31: 281.)
108. [107] A statement by the Advanced Cardiac Life Support Committee of the European Resuscitation Council, 1994, [1] updated 1992 [2] and 1998. Peri-arrest arrhythmias: the management of arrhythmias associated with cardiac arrest. In: L Bossaert, ed. European Resuscitation Council Guidelines for Resuscitation. Amsterdam. Elsevier 1998; 159-67.
109. [108] Cotter G, Metzkor E, Kaluski E et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-93.
110. [109] Timmis AD, Fowler MB, Chamberlain DA. Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction. Br Med J 1981; 282: 7-9.
111. [110] Dracup K, Heany DM, Taylor SE, Guzy PM, Breu C. Can family members of high-risk cardiac patients learn cardiopulmonary resuscitation? Arch Intern Med 1989; 149: 61-4.
112. [111] The 1998 European Resuscitation Council guidelines for adult single rescuer basic life support. A statement from the Working Group on Basic Life Support, and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 1998; 37: 67-80.
113. [112] Wenzel V, Idris AH, Banner MJ, Fuerst RS, Tucker KJ. The composition of gas given by mouth-to-mouth ventilation during CPR. Chest 1994; 106: 1806-10.
114. [113] Moser DK, Coleman S. Cardiopulmonary resuscitation: recommendations for improving cardiopulmonary resuscitation skills retention. Heart Lung 1992; 32: 372-80.
115. [114] Berg RA, Kern KB, Hilwig RW et al. Assisted ventilation does not improve outcome in a porcine model of single-rescuer bystander cardiopulmonary resuscitation. Circulation 1997; 95: 1635-41.
116. [115] Van Hoeyweghen RJ, Bossaert LL, Mullie A et al. the Belgium Cerebral Resuscitation Study Group. Quality and efficency of bystander CPR. Resuscitation 1993; 26: 47-52.
117. [116] Ornato JP. Should bystanders perform mouth-to-mouth ventilation during resuscitation. Chest 1994; 106: 1641-2.
118. [117] Locke CJ, Berg RA, Sanders AB et al. Bystander cardiopulmonary resuscitation: concerns about mouth-to-mouth contact. Arch Intern Med 1995; 155: 938-43.
119. [118] The 1998 European Resuscitation Council guidelines for adult advanced life support. A statement from the Working Group on Advanced Life Support, and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 1998; 37: 81-90.
120. [119] Jakobsson J, Rehnqvist N, Nyquist O. Energy requirement for early defibrillation. Eur Heart J 1989; 10: 551-4.
121. [120] Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defibrillation: a comparative trial using 175J and 320J shocks. N Engl J Med 1982; 307: 1101-6.
122. [121] Kern KB, Ewy GA. Clinical defibrillation: Optimal transthoracic and open heart techniques. In: WA Tacker Jr, ed. Defibrillation of the heart, ICDs, AEDs and Manual. St Louis Missouri, Mosby-Yearbook, Inc. 1994. 133-160.
123. [122] Bardy GH, Gliner BE, Kudenchuk PJ et al. Truncated biphasic pulses for transthoracic defibrillation. Circulation 1995; 91: 1768-74.
124. [123] Reddy R, Gleva MJ, Glina BE et al. Biphasic transthoracic defibrillation causes fewer ECG ST-segment changes after shock. Ann Emerg Med 1997; 30: 127-34.
125. [124] Weisfeldt ML, Kerber RE, McGoldrick P et al. Public access defibrillation: A Statement for Healthcare Professionals from the American Heart Associaton Task Force on Automatic External Defibrillation. Circulation 1995; 92: 2763.
126. [125] A Statement by the Airway and Ventilation Management Working Group of the European Resuscitation Council. Guidelines for the advanced management of the airway and ventilation during resuscitation. Resuscitation 1996; 31: 201-30.
127. [126] Hapnes SA, Robertson C. CPR - drug delivery routes and systems. Resuscitation 1992; 24: 137-42.
128. [127] Aitkenhead AR. Drug administration during CPR: what route? Resuscitation 1991; 22: 191-5.
129. [128] Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in pre-hospital cardiac arrest. JAMA 1992; 268: 2667-72.
130. [129] Lindner KH, Prengel AW, Pfenninger EG et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995; 91: 215-21.
131. [130] Lindner KH, Dirks B, Strohmenger H-U, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997; 349: 535-7.
132. [131] Koster R, Carli P. Acid-base management. A statement for the Advanced Life Support Working Party of the European Resuscitation Council. Resuscitation 1992; 24: 143-6.
133. [132] Tzivoni D, Banai S, Schuger C et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77: 392-7.
134. [133] Wiesfeld ACP, Crijns JGM, Tuininga YS, Lie KI. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pace 1996; 19: 1026-35.
135. [134] Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367-79.
136. [135] Siesjö BK. Historical overview: calcium, ischemia and death of brain cells. Ann NY Acad Sci 1988; 522: 638-61.
137. [136] Gustafson I, Edgren E, Hulling J. Brain-oriented intensive care after resuscitation from cardiac arrest. Resuscitation 1992; 24: 245-61.
138. [137] Kern KB, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA. A study of chest compression rates during cardiopulmonary resuscitation in humans. Arch Intern Med 1992; 152: 145-9.
139. [138] Trillo G, von Planta M, Kette F. ETCO2 monitoring during low flow states: clinical aims and limits. Resuscitation 1994; 27: 1-8.
140. [139] Beauchamp TL, Chindress JF. Principles of biomedical ethics. Oxford: Oxford University Press, 1989.
141. [140] Gillon R. Philosophical medical ethics. Chichester: John Wiley & Sons, 1985.
142. [141] Tomlinson, T, Brody H. Ethics and communication in do-not-resuscitate orders. N Eng J Med 1988; 318: 43-6.
143. [142] Florin , D. Do not resuscitate orders: the need for the policy. J Royal Coll Phys 1993; 27: 1358.
144. [143] Hartford M, Karlson BW, Sjolin M, Holmberg S, Herlitz J. Symptoms, thoughts, and environmental factors in suspected acute myocardial infarction. Heart-Lung 1993; 22: 64-70.
145. [144] Dellipiani AW, Cay EL, Phillip AE et al. Anxiety after a heart attack. Br Heart J 1976; 38: 752-7.
146. [145] Vetter NJ, Cay EL, Phillip AE, Strange RC. Anxiety on admission to a coronary care unit. J Psychosomatic Res 1977; 21: 73-8.
147. 146] Thompson DR, Cordle CJ, Sutton TW. Anxiety in coronary patients. Int Rehab Med 1982; 4: 161-4.
148. [147] Harrison TR, Reeves TJ. Ischemic heart disease. Chicago Year Book, 1968: 295.